Search Results 71-80 of 23188 for Celiac disease

  1. Celiac disease / ductal carcinoma in situ / eating smart during the holidays: Mayo Clinic Radio

    On this Mayo Clinic Radio podcast, Dr. Joseph Murray, a Mayo Clinic gastroenterologist, will discuss diagnosing and treating celiac disease.

  2. A Study of Simvastatin Metabolism as a Test for Celiac Disease Activity - Mayo Clinic

    ... celiac disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  3. VTP-1000 In Celiac Disease - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study of the Response to and Changes in Intestinal Permeability 4 hours after a Gluten Challenge in Subjects with Celiac Disease and Non Celiac Gluten Sensitivity - Mayo Clinic

    A Study of the Response to and Changes in Intestinal Permeability 4 hours after a Gluten Challenge in Subjects with Celiac Disease and Non Celiac Gluten ...

  5. Gut Permeability Assessment in Celiac and Gluten Sensitive Children - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Mayo Clinic

    celiac disease marketing campaign landing - video. Sections. Products and ... celiac disease marketing campaign landing - video. Your gift multiples 2X.

  7. Evaluation Of The Efficacy And Safety Of ALV003 In Symptomatic In Celiac Disease Patients - Mayo Clinic

    ... and symptoms in celiac disease patients. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  8. Blood Pressure Drug Creates Severe GI Problems And Symptoms Of Celiac Disease - Mayo Clinic News Network

    Blood Pressure Drug Creates Severe GI Problems And Symptoms Of Celiac Disease ... celiac disease. Lead author and Mayo Clinic gastroenterologist, Joseph ...

  9. A Study To Evaluate The Safety, Effectiveness, And Tolerability Of Latiglutenase To Treat Patients With Well-Controlled Celiac Disease - Mayo Clinic

    A Study To Evaluate The Safety, Effectiveness, And Tolerability Of Latiglutenase To Treat Patients With Well-Controlled Celiac Disease · Share · Facebook · Twitter.

  10. A Study of the Safety, Effectiveness and Tolerability of Nexvax-2 in Patients with Celiac Disease (CeD) - Mayo Clinic

    The purpose of this study is to evaluate the human leukocyte antigen (HLA)-DQ 2.5+ in adults with celiac disease (CeD). Participation eligibility. Participant ...